Baseline clinical characteristics
| Data are presented as number (%) of patients or mean (SD). | |
| *Patients receiving oral antidiabetic agents or insulin. | |
| †Defined as a total cholesterol ⩾6.4 mmol/l or treatment with lipid lowering medication. | |
| ‡Defined as blood pressure ⩾140/90 mm Hg or treatment with antihypertensive medication. | |
| ACE, angiotensin converting enzyme; CABG, coronary artery bypass grafting; LVEF, left ventricular ejection fraction; PTCA, percutaneous transluminal coronary angioplasty. | |
| Male sex | 69 (85%) |
| Age (years) | 61 (10) |
| LVEF (%) | 323 (10)8 |
| Diabetes mellitus* | 6 (7%) |
| Hypercholesterolaemia† | 36 (44%) |
| Systemic hypertension‡ | 28 (35%) |
| Current smoking | 30 (37%) |
| History of angina | 50 (62%) |
| Previous revascularisation | |
| PTCA | 13 (16%) |
| CABG | 20 (35%) |
| Medication | |
| β Blockers | 40 (49%) |
| ACE inhibitors | 51 (63%) |